for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be transferred on share sale and purchase date from the seller’s connected

established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be

skin medicine under trademarks including trademark of “DERMALIS”, (which will be Criterion Calculation Method Transaction size 1. Net tangible assets (NTA) Proportion of assets acquired (100%) x NTA AT

debentures including type, name, interest rate, redemption date, appointment of bondholders' representative including specifications related to the offering, including but not limited to price method and

mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. The company’s net income in

such as mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. Profit

Period As Of Details JAKPAISAN ESTATE PUBLIC COMPANY LIMITED 2023 Reviewed Equity Method Statement Q2 30/06/2023 JAKPAISAN ESTATE PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 JAKPAISAN ESTATE

higher revenue per visit of non-social security category but also from the efficient cost control of medicine and supplies as well as staff. Administrative Expenses Administrative expenses decreased by 13

IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of

Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton